Literature DB >> 26730494

Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.

Jui-Chih Chang1, Shey-Lin Wu2, Ko-Hung Liu1, Ya-Hui Chen1, Chieh-Sen Chuang2, Fu-Chou Cheng3, Hong-Lin Su4, Yau-Huei Wei5, Shou-Jen Kuo6, Chin-San Liu7.   

Abstract

Although restoration of mitochondrial function in mitochondrial diseases through peptide-mediated allogeneic mitochondrial delivery (PMD) has been demonstrated in vitro, the in vivo therapeutic efficacy of PMD in Parkinson's disease (PD) has yet to be determined. In this study, we compared the functionality of mitochondrial transfer with or without Pep-1 conjugation in neurotoxin (6-hydroxydopamine, 6-OHDA)-induced PC12 cells and PD rat models. We injected mitochondria into the medial forebrain bundle (MFB) of the PD rats after subjecting the nigrostriatal pathway to a unilateral 6-OHDA lesion for 21 days, and we verified the effectiveness of the mitochondrial graft in enhancing mitochondrial function in the soma of the substantia nigra (SN) neuron through mitochondrial transport dynamics in the nigrostriatal circuit. The result demonstrated that only PMD with allogeneic and xenogeneic sources significantly sustained mitochondrial function to resist the neurotoxin-induced oxidative stress and apoptotic death in the rat PC12 cells. The remaining cells exhibited a greater capability of neurite outgrowth. Furthermore, allogeneic and xenogeneic transplantation of peptide-labeled mitochondria after 3 months improved the locomotive activity in the PD rats. This increase was accompanied by a marked decrease in dopaminergic neuron loss in the substantia nigra pars compacta (SNc) and consistent enhancement of tyrosine hydroxylase-positive immunoreaction of dopaminergic neurons in the SNc and striatum. We also observed that in the SN dopaminergic neuron in the treated PD rats, mitochondrial complex I protein and mitochondrial dynamics were restored, thus ameliorating the oxidative DNA damage. Moreover, we determined signal translocation of graft allogeneic mitochondria from the MFB to the calbindin-positive SN neuron, which demonstrated the regulatory role of mitochondrial transport in alleviating 6-OHDA-induced degeneration of dopaminergic neurons.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26730494     DOI: 10.1016/j.trsl.2015.12.003

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  32 in total

Review 1.  Inter and Intracellular mitochondrial trafficking in health and disease.

Authors:  Santhanam Shanmughapriya; Dianne Langford; Kalimuthusamy Natarajaseenivasan
Journal:  Ageing Res Rev       Date:  2020-07-23       Impact factor: 10.895

Review 2.  Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.

Authors:  Bhupendra Singh; Josephine S Modica-Napolitano; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-11       Impact factor: 15.707

Review 3.  Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases.

Authors:  Amaneh Mohammadi Roushandeh; Yoshikazu Kuwahara; Mehryar Habibi Roudkenar
Journal:  Cytotechnology       Date:  2019-01-31       Impact factor: 2.058

4.  Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury.

Authors:  J L Gollihue; C M Norris
Journal:  Ageing Res Rev       Date:  2020-02-24       Impact factor: 10.895

5.  Effects of Mitochondrial Transplantation on Bioenergetics, Cellular Incorporation, and Functional Recovery after Spinal Cord Injury.

Authors:  Jenna L Gollihue; Samir P Patel; Khalid C Eldahan; David H Cox; Renee R Donahue; Bradley K Taylor; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2018-04-30       Impact factor: 5.269

Review 6.  Therapeutic use of extracellular mitochondria in CNS injury and disease.

Authors:  Yoshihiko Nakamura; Ji-Hyun Park; Kazuhide Hayakawa
Journal:  Exp Neurol       Date:  2019-11-14       Impact factor: 5.330

7.  Mitochondrial Transplantation Attenuates Brain Dysfunction in Sepsis by Driving Microglial M2 Polarization.

Authors:  Zhanqin Zhang; Qiang Wang; Chaoying Yan; Zhi Ma; Hongli Ma; Qing Li; Qian Zhai; Tao Jiang
Journal:  Mol Neurobiol       Date:  2020-07-01       Impact factor: 5.590

Review 8.  Extracellular Mitochondria for Therapy and Diagnosis in Acute Central Nervous System Injury.

Authors:  Kazuhide Hayakawa; Morgan Bruzzese; Sherry H-Y Chou; MingMing Ning; Xunming Ji; Eng H Lo
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

Review 9.  Mitochondrial transplantation: applications for pediatric patients with congenital heart disease.

Authors:  Sitaram M Emani; James D McCully
Journal:  Transl Pediatr       Date:  2018-04

Review 10.  Mesenchymal Stem Cell-Mediated Mitochondrial Transfer: a Therapeutic Approach for Ischemic Stroke.

Authors:  Meng Lu; Jindong Guo; Bowen Wu; Yuhui Zhou; Mishan Wu; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Transl Stroke Res       Date:  2020-09-25       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.